As of January 1, 2026 — Elon Musk’s Neuralink achieved unprecedented progress in 2025, pushing brain-computer interface (BCI) technology forward through regulatory milestones, international clinical trials, substantial funding, and significant hardware advancements. These developments bring the company closer to restoring lost functions for patients with severe neurological conditions while laying groundwork for broader applications.
FDA Breakthrough Device Designation for Speech Restoration
In 2025, Neuralink earned FDA Breakthrough Device Designation for its speech restoration technology, specifically designed for individuals with severe speech impairments, including those affected by ALS or stroke. This designation expedites the development and review process, highlighting the urgent need and innovative potential of decoding thoughts into spoken words.
$650 Million Series E Funding Round
Neuralink secured $650 million in Series E funding, led by high-profile investors such as ARK Invest, Sequoia Capital, and Founders Fund. The round valued the company at approximately $9 billion, providing critical capital to accelerate global trials, refine manufacturing, and develop next-generation implants.
International Clinical Trial Expansion
2025 saw Neuralink extend its clinical studies beyond the United States for the first time:
- UAE-PRIME Trial (Middle East): Launched in partnership with Cleveland Clinic Abu Dhabi and the Department of Health Abu Dhabi, marking Neuralink’s inaugural trial in the region.
- GB-PRIME Trial (United Kingdom): Conducted with University College London Hospitals and Newcastle Hospitals. The first UK participant, Paul—a patient with motor neuron disease—received his implant and successfully controlled a computer using thoughts just hours post-surgery.
- CAN-PRIME Trial (Canada): University Health Network in Toronto performed Neuralink’s first procedures outside the US, implanting devices in two patients with cervical spinal cord injuries.
These international efforts complement the ongoing US PRIME study, where participants have demonstrated reliable control of computers, smartphones, and other devices through thought alone.
CONVOY Project: Advancing Thought-Controlled Robotics
The CONVOY feasibility study progressed notably in 2025, enabling participants to control advanced robotic arms using their Neuralink implants. Demonstrations showcased practical tasks such as grasping objects and self-feeding, representing a major step toward restoring physical independence.
Next-Generation Surgical Robot Enhancements
Neuralink unveiled a significantly upgraded version of its R1 surgical robot, featuring:
- Electrode thread insertion time reduced to 1.5 seconds per thread
- Increased insertion depths exceeding 50mm
- Enhanced compatibility with 99% of global anatomical variations
- 95% reduction in manufacturing costs for needle cartridges
Additional innovations include more flexible electrode threads for safer and more precise neuron targeting. These improvements support Neuralink’s long-term goal of rapid, minimally invasive procedures—comparable to LASIK—that could be completed in minutes on an outpatient basis.
Outlook for 2026 and Beyond
With a patient registry exceeding 10,000 individuals and plans to perform 20–30 additional implants in the coming year, Neuralink is scaling operations rapidly. Upcoming priorities include expanding speech restoration capabilities, initiating vision restoration trials (Blindsight), and deeper integration with external robotics.
Neuralink’s accomplishments in 2025 demonstrate the accelerating pace of BCI development and its potential to transform lives for those with paralysis, speech loss, and other neurological challenges.
For more information on participating in Neuralink trials, visit the official patient registry at neuralink
Ethan Brooks covers the tech that’s reshaping how we move, work, and think — for VFuture Media. He was at CES 2026 in Las Vegas when the world got its first real look at humanoid robots, AI-powered vehicles, and Samsung’s tri-fold phone. He writes about AI, EVs, gadgets, and green tech every week. No hype. No filler. X · Facebook
Honestly, we’re still debating this one in the comments. Where do you land? Drop your take below — the best discussions on this site have always come from readers who actually know their stuff.
Leave a Comment